Apollo Therapeutics

Apollo Therapeutics is a portfolio-based biopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs built on breakthrough discoveries. By deeply collaborating with world-leading scientists and inventors, the company identifies programs with strong biological hypotheses and the potential to become meaningful new treatment options. Apollo's model combines the "architects" of drug development with deep subject matter experts, establishing an expansive and de-risked pipeline across oncology, major inflammatory diseases, and rare diseases.